Stocks
AxoGen (AXGN) EBITDA margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -17.6% | -16.5% | -18.1% | -10.0% | -7.79% | |||
| Changes by years, y/y, % | +7pp | +1pp | +16pp | +8pp | -15.7% | ||||
AxoGen. EBITDA margin, %
AxoGen. EBITDA margin, changes, pp
AxoGen (AXGN) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -16.9% | -16.1% | -6.36% | -3.12% | -6.44% | -7.79% | |
| Changes by years, y/y, % | +16pp | +4pp | +3pp | +10pp | +10pp | |||
| Changes by quarters, q/q, % | -4pp | +1pp | +10pp | +3pp | -3pp | |||
